Ultragenyx Pharmaceutical

-$1.00 (-1.23%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita.

CEO
Emil D. Kakkis
Employees
893
Headquarters
Novato, California
Founded
2010

RARE Key Statistics

Market Cap
5.43B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
368.38K
High Today
$82.66
Low Today
$79.68
Open Price
$81.27
Volume
359.40K
52 Week High
$179.65
52 Week Low
$76.78

RARE News

Simply Wall St7h

Have Ultragenyx Pharmaceutical Inc. Insiders Been Selling Their Stock?

Anyone interested in Ultragenyx Pharmaceutical Inc. ( ) should probably be aware that the Executive VP & CFO, Mardi Dier, recently divested US$288k worth of sha

RARE Earnings

-$2.05
-$1.37
-$0.68
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 26, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure